Mesoblast Limited (ASX:MSB)
Share Pricing & News Healthcare

AUD 0.78

-0.01 (1.266%)
(As on 2022-10-03 09:36:48 AEDT)
Previous Close Open Close*
0.79 0.785 0.78
Market Cap Dividend Yield (Annualized)
AUD 574.531M

Day Range
0.76L 0.785 H
52 WEEK HIGH LOW
0.61L 1.95 H

Chart Price & Information

Last Trade 0.78
Change% -1.2658
52 W H/L 1.950/0.610
EBITDA -70.3M
NPAT After Abnormal Items 0
Equity 0
ROE%
Total Liabilities 0
Total Revenue 0
Cash and Cash Equivalents 0

Stock Information

Share price 0.78
Market Cap 574.531M
Price/Gross Cash Flow
Dividend Yield Excluding Special
Ending Shares 0
52-Week Range 1.950-0.610
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized)
Earnings Yield 46.270
Net Tangible Asset (NTA)
P/E ratio 2.161
Sector P/E
EPS
EV/EBITDA
Net Profit Margin (%)
Gross Cash Flows Per Share
Net Gearing
Sales Per Share
Book Value Per Share

Similar Companies

Related Articles

About Company

ASX-listed, Melbourne headquartered health care player Mesoblast Limited (ASX:MSB) is a frontrunner in developing innovative cellular medicines across the globe. MSB has a strong emerging drug pipeline with its three programs currently under phase III clinical studies. The lead drug candidates of Mesoblast remestemcel-L, revascor, MPC-300-IV and MPC-06-ID are under clinical development. The Company has a robust and broad worldwide intellectual property portfolio with protection extending through to at least 2040 in all main markets.

Corporate Information


Level 38, 55 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000

Phone:(03) 9639 6036

Website:http://www.mesoblast.com

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Prelim) 2023-08-30 2023
Report (Interim) 2023-02-24 2023
Report (Annual) 2022-10-28 2022